Management of Cardiovascular Disease During Coronavirus Disease (COVID-19) Pandemic

Area of Science:

• Cardiology
• Infectious Diseases
• Public Health

Background:

• Patients with pre-existing cardiovascular disease (CVD) face higher risks from novel coronavirus disease-2019 (COVID-19).
• Emerging reports indicate cardiac injury and new-onset heart complications (myocarditis, arrhythmia, heart failure) in COVID-19 patients, potentially from immune responses.
• The COVID-19 pandemic strains healthcare systems, creating a need for standardized cardiovascular care protocols.

Purpose of the Study:

• To provide consensus guidance for managing cardiovascular conditions during the COVID-19 pandemic.
• To ensure optimal patient care for both COVID-19-related and traditional cardiovascular issues.
• To minimize exposure risks for frontline healthcare workers.

Main Methods:

• Development of consensus-based recommendations.
• Review of current literature on COVID-19 and cardiovascular complications.
• Integration of established cardiovascular care principles with pandemic-specific considerations.

Main Results:

• Standardized management strategies are proposed for various cardiovascular conditions amidst the pandemic.
• Guidance addresses the unique challenges posed by COVID-19's impact on cardiac health.
• Recommendations aim to balance effective treatment with infection control measures.

Conclusions:

• A standardized approach is crucial for managing cardiovascular disease during the COVID-19 pandemic.
• This guidance supports healthcare providers in delivering safe and effective care to all cardiovascular patients.
• Proactive management strategies are essential to mitigate adverse outcomes and protect healthcare resources.